| Literature DB >> 29087849 |
Xin Chen1, Abrar Ahmad Chughtai1, C Raina MacIntyre1.
Abstract
INTRODUCTION: In the era of genetic engineering of pathogens, distinguishing unnatural epidemics from natural ones is a challenge. Successful identification of unnatural infectious disease events can assist in rapid response, which relies on a sensitive risk assessment tool used for the early detection of deliberate attacks (i.e., bioterrorism).Mesh:
Year: 2017 PMID: 29087849 PMCID: PMC7107703 DOI: 10.7205/MILMED-D-17-00090
Source DB: PubMed Journal: Mil Med ISSN: 0026-4075 Impact factor: 1.437
FIGURE 1.Search strategy and selection of papers.
The Peer-Reviewed Papers Associated with Scoring Systems of Bioterrorism-Related Outbreak Detection
| Reference of Study | Name of Scoring System | Number of Criteria | Listed Criteria | Maximum Score (Cutoffs) | Used for Agents or Previous Outbreaks | Correct Identification | Applicable to Other Diseases | Real Time Use | Objective | Strengths/ |
|---|---|---|---|---|---|---|---|---|---|---|
| Grunow et al. 2002 | Grunow-Finke epidemiological assessment tool | 13 | 1. Bio-risk 2. Bio-threat | 54 (0–17: Unlikely; 18–35: Doubtful; 36–50: Likely; 51–54: Highly Likely) | 1. 1915, Anthrax, USA | 8 of 13 (62%) | Yes | Yes | Differentiating between natural and unnatural outbreaks | Most widely used; Quantitative measurements for criteria; |
| 3. Peculiarities of the intensity and dynamics of the epidemic | 2. 1971, Smallpox, Aralsk | |||||||||
| 4. Peculiarities of the transmission mode of the biological agent | 3. 1979, Anthrax, Sverdlovsk | |||||||||
| 5. Peculiarities of the time of the epidemic | 4. 1984, Salmonella, Oregon | |||||||||
| 6. Unusually rapid spread of the epidemic | 5. 1995, Anthrax, Tokyo; | |||||||||
| 7. Limitation of the epidemic to a specific population | 6. 1996, Shigella, Texas | |||||||||
| 8. Peculiarities of the clinical manifestation | 7. 1999, WNV, NYC; | |||||||||
| 9. Special aspects of the biological agent | 8. 1999, Tularaemia Kosovo | |||||||||
| 10. Peculiarities of the geographic distribution of the biological agent | 9. 2000, Tularemia, USA | |||||||||
| 11. High concentration of the biological agent in the environment | 10. 2001, Anthrax, USA | |||||||||
| 12. Identification of the agent as a biological warfare agent | 11. 2011, Haemolytic-uremic syndrome, Germany | |||||||||
| 13. Proof of the release of the agent by a biological weapon | 12. 2003, Ricin, USA | |||||||||
| 13. 2013, Rabies, Taiwan, China | ||||||||||
| Dembek et al. 2007 | Potential epidemiological clues to a deliberate epidemic | 11 | 1. A highly unusual event with large numbers of casualties | NA | 1. 1984, Salmonella, Oregon; | 4 of 6 (67%) | Yes | Yes | Evidence-based clues of deliberate epidemic | Widely used; Zoonotic diseases included; |
| 2. Higher morbidity or mortality than is expected | 2. 1996, Shigella, Texas; | |||||||||
| 3. Uncommon disease | 3. 2001, Anthrax, USA; | |||||||||
| 4. Point-source outbreak | 4. 1979, Anthrax, Sverdlovsk; | |||||||||
| 5. Multiple epidemics | 5. 1999, WNV, NYC; | |||||||||
| 6. Lower attack rates in protected Individuals | 6. 2000, Tularemia, Kosovo | |||||||||
| 7. Dead animals | ||||||||||
| 8. Reverse spread | ||||||||||
| 9. Unusual disease manifestation | ||||||||||
| 10. Downwind plume pattern | ||||||||||
| 11. Direct evidence | ||||||||||
| Radosavljevic et al. 2009 | Bioterrorism risk assessment (BTRA) scoring | 23 | 1. Type of perpetrator (government institutions/organizations, terrorist groups, individuals) 2. Sophistication, motivation, ability, capacity 3. Intelligence/secrecy (global and local) 4. Number of perpetrators 5. Distribution of perpetrators (accessibility to sources of agent and accessibility to the target) | 23 (NA) | 2001, Anthrax, USA | 1 of 1 (100%) | Yes | Not yet | The likelihood of a bioterrorism risk | Subtle and detailed criteria; |
| 6. Type of agent 7. Accessibility to terrorists 8. Amounts of the available agent 9. Air 10. Food 11. Water 12. Fomites 13. Munitions 14. Delivery systems 15. Dispersion systems 16. Intelligence/secrecy (global and local) 17. Personal/individual control | ||||||||||
| 18. Control of media (air, food, and water) 19. Control of fomites (office equipment, postal letters, etc.) | ||||||||||
| 20. Parameters of protection (physical, chemical, immunological) | ||||||||||
| 21. Number of people in the target | ||||||||||
| 22. Distribution of people in the target 23. Location of the target | ||||||||||
| Radosavljevic et al. 2012 | NA | 14 | 1. Unusual/atypical disease/manifestation (symptoms/signs) or unexpected fulminant course of disease in humans and/or animals | 14 (1–4: Natural epidemic; 5–9: Probable deliberate or accidental outbreak; 10–14: Highly probable deliberate or accidental outbreak) | 1. 2009, Swine flu, Mexico and North America; 2. 2000, Tularemia, Kosovo; 3. 1979, Anthrax, Sverdlovsk | 2 of 3 (67%) | Yes | Not yet | Early detection and quick orientation of UEEs | Refined criteria; |
| 2. Failure of patient to respond to usual therapy or illness in a population (human, animal) despite immunizations | ||||||||||
| 3. Several unusual/unexplained syndromes co-existing in the same case without any other explanation | ||||||||||
| 4. Sudden unexplainable increase in the number of cases or deaths in human and/or animal populations | ||||||||||
| 5. Morbidity and/or mortality higher than expected | ||||||||||
| 6. Clustering of patients with fever and/or fever and respiratory symptoms and/or lymphadenopathy | ||||||||||
| 7. Disease identified in the region for the first time ever or again after a long period of time | ||||||||||
| 8. Disease with an unusual/atypical seasonal distribution | ||||||||||
| 9. Simultaneous occurrence of epidemics and/or epizootics | ||||||||||
| 10. Explosive epidemics and/or epizootics with indicators on a point-source origin 11. Disease with an unusual geographic distribution | ||||||||||
| 12. Occurrence of a non-endemic (imported) or previously eradicated disease | ||||||||||
| 13. Epidemiological data suggesting a common exposure | ||||||||||
| 14. Simultaneous epidemics and/or epizootics occur at different locations | ||||||||||
| Radosavljević et al. 2016 | NA | 33 | Perpetrator/source of infection/reservoir of pathogen 1. Sophistication 2. Motivation 3. Intention 4. Intelligence 5. Secrecy 6. Number of perpetrators 7. Number of sources of infection/reservoirs 8. Accessibility to sources of agent/pathogen 9. Accessibility to targets/population at risk | 33 (0–8: Lowly probable type of outbreak (TO); 9–16: possible type of TO; 17–24: Highly probable TO; 25–33: Certain TO) | 2011, Haemolytic-uremic syndrome, Germany | 1 of 1 (100%) | Yes | Yes | Differentiating scoring for a natural outbreak of an endemic disease, a natural outbreak of a new/re-emerging disease, an accidental release and a deliberate outbreak | Most refined criteria; |
| Biological agent/pathogen 10. A category 11. B category 12. C category 13. Emerging pathogen 14. Amount of the available agent/pathogen | ||||||||||
| Means/media of delivery/factors of transmission 15. Air 16. Food 17. Water 18. Fomites 19. Vectors 20. Biological ammunition 21. Delivery systems 22. Dispersion systems/mechanism of release Target/susceptible population at risk 23. Intelligence 24. Secrecy 25. Personal control 26. Control of means/media of delivery/factors of transmission 27. Physical protection 28. Protection by chemoprophylaxis 29. Protection by immuno-prophylaxis 30. Importance of target/population at risk 31. Location of target/population at risk 32. Number of people in a target/population at risk 33. Distribution of people in a target/population at risk |
NA, not applicable.